New data on greenhouse gas and ammonia emissions Greenhouse gas emissions have fallen slightly; ammonia emissions remain stable.
Humans themselves are the most important source of ESBL Antibiotic Resistance Human to human transfer is the main source of ESBL (Extended Spectrum Beta-Lactamase) antibiotic resistance, according to researchers from the ESBLAT research consortium, of which RIVM is a member.
Medication may affect diagnostic tests The use of medication may affect diagnostic tests. This may distort the results of those tests.
Mild 2018-2019 influenza epidemic The annual influenza epidemic in the winter of 2018-2019 was less severe than the year before. Approximately 400,000 people have had the flu.
Antibiotic resistance no longer increasing but vigilance remains necessary After continuing to rise for many years, in 2013 the prevalence of resistance to antibiotics levelled out somewhat in both hospitals and primary care.
Need for reliable data on ammonia emissions Many countries in Europe and Central Asia have a need for reliable data on ammonia emissions. These data include ammonia emissions inventories and monitoring of abatement measures.
RIVM forecasting study: a healthier Netherlands with more people living with a chronic disease Dutch people are reaching an increasingly advanced age: in 2030, the life expectancy of men will be 82 years, and of women, 85.
Animation Antibiotic Resistance RIVM monitors and informs the government about potential national health threats with regard to antibiotic resistance. Based on a national AMR surveillance system trends are monitored.
Twenty million post-polio patients are dealing with severe complaints on a daily basis The second European Polio Conference takes place in Amsterdam from 25 - 27 June 2014, with the theme of the ‘Post-Polio Syndrome, A Condition without Boundaries’.
International top conference about antibiotic resistance On 25 and 26 June, an international conference about resistance to antibiotics - an increasing worldwide problem - will take place in The Hague.